Hidalgo County Clerk’s office shows their support for Breast Cancer Awareness

Breaking NewsCommunity News
750

Translate to Spanish or other 102 languages!

Hidalgo County Clerk Arturo Guajardo Jr. (center) with Mario Lizacano, Doctor’s Hospital at Renaissance Administrator of Corporate Affairs (in suit, far right) and County Clerk employees.

Mega Doctor News

- Advertisement -

EDINBURG – Employees from the Hidalgo County Clerk’s Office are bringing awareness to Breast Cancer during the month of October. The employees from County Clerk Arturo Guajardo Jr.’s office are wearing pink every Monday to show love and support for all cancer survivors and honor those taken by this deadly disease.

As a way to educate employees, Guajardo asked Mario Lizcano, Doctor’s Hospital at Renaissance Administrator of Corporate Affairs, to give a short presentation to the staff. Lizcano spoke about the importance of annual checkups, how to recognize symptoms and the different types of preventative measures available.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Valley Baptist-Harlingen Pediatric Emergency Room Now Open to Public
Next article
Former Patient Uses His “Wish” to Donate Toys to Playroom at the Children’s Center at Renaissance

More Articles

Scientists Reverse Brain Aging With a Nasal Spray

Picture this: your brain is a high-performance engine. Over decades, it doesn’t just wear down; it also starts to run hot.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 
- Advertisement -